Table 1 A comprehensive comparison of baseline characteristics between the groups exhibiting lymphatic leakage and those without
characteristics | Lymphatic leakage | No lymphatic leakage | P-value |
|---|---|---|---|
n | 254(47.6%) | 280(52.4%) | |
Gender, n (%) | 0.054 | ||
Male | 216 (49.5%) | 220 (50.5%) | |
Female | 38 (38.8%) | 60 (61.2%) | |
Age, median (IQR) | 67 (61, 73) | 68 (60, 75) | 0.184 |
Weight(kg), mean ± sd | 67.19 ± 11.39 | 67.912 ± 12.285 | 0.486 |
Height(cm), median (IQR) | 170 (164, 173) | 168 (162, 172) | 0.016 |
BMI, median (IQR) | 23.457 (21.453, 25.808) | 24.535 (21.97, 26.57) | 0.014 |
Previous history of adjuvant therapy, n (%) | 0.088 | ||
No | 186 (50%) | 186 (50%) | |
Yes | 68 (42.0%) | 94 (58.0%) | |
Smoking history, n (%) | 0.340 | ||
No | 226 (46.9%) | 256 (53.1%) | |
Yes | 28 (53.8%) | 24 (46.2%) | |
ASA score, n (%) | 0.546 | ||
1 | 27 (54%) | 23 (46%) | |
2 | 191 (47.8%) | 209 (52.2%) | |
3 | 29 (43.3%) | 38 (56.7%) | |
4 | 0 (0%) | 1 (100%) | |
Preoperative hemoglobin(g/L), median (IQR) | 134 (118.25, 146) | 132 (113, 145) | 0.352 |
Preoperative creatinine(umol/L), median (IQR) | 85 (75, 101) | 87.5 (74, 105.75) | 0.443 |